A multinational healthcare behemoth that offers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products was looking to establish an analytics model for managing supply and demand of its drugs during the COVID19 pandemic. They aspired to automate and scale processes to expedite processing, visualization and alert leadership of trending new infection rates to help predict demand more accurately.
HCLTech came onboard to help the customer reimagine its data and analytics capabilities through a strategic transformation exercise. Our approach involved analysis of patient demographics vial usage, vial demand forecasting, real-time COVID dashboards and forecasting COVID effects on vial demand. Our partnership with the customer resulted in a cohesive data and analytics foundation aligned to their strategic business outcomes, thus fueling data-driven digital enablement across the enterprise. It led to significant improvement in forecast accuracy, reduction in working capital and reduction in shipping and distribution costs. Download the case study to know more.